Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Dracen Pharmaceuticals
AddedFeb 17, 2024
UpdatedJun 18, 2026
Dracen Pharmaceuticals

Dracen Pharmaceuticals

Dracen Pharmaceuticals: Innovating cancer treatment through novel glutamine antagonists.

HQ
Baltimore, MD, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to innovate cancer treatment, Dracen Pharmaceuticals focuses on developing novel glutamine antagonists aimed at improving outcomes for cancer patients. The company leverages immuno-metabolism to create potential new treatments, specifically targeting advanced solid tumors and fibrolamellar carcinoma. Their market focus is on providing advanced therapeutic options for patients with limited treatment choices, thereby addressing significant unmet medical needs in oncology.

Dracen Pharmaceuticals has notable affiliations, including a clinical collaboration with Merck and support from the Fibrolamellar Cancer Foundation (FCF). Key achievements include the initiation of a first-in-human study of their lead compound, DRP-, and a phase I/II study in combination with Durvalumab for fibrolamellar carcinoma. These milestones underscore Dracen's impact on advancing cancer treatment and their commitment to bringing innovative therapies to market.

Dracen Pharmaceuticals - Similar Companies

Novita Pharmaceuticals logo

Novita Pharmaceuticals

novita-pharm.com

Onchilles Pharma logo

Onchilles Pharma

Cage Pharma logo

Cage Pharma

cagephar.ma

Lite Strategy logo

Lite Strategy

meipharma.com

NextCure logo

NextCure

nextcure.com

Toragen logo

Toragen

toragen.com

BioNumerik Pharmaceuticals logo

BioNumerik Pharmaceuticals

Duet BioTherapeutics logo

Duet BioTherapeutics

Rainier Therapeutics logo

Rainier Therapeutics

Trio Pharmaceuticals logo

Trio Pharmaceuticals

Palleon Pharmaceuticals logo

Palleon Pharmaceuticals

palleonpharma.com

ImmunoMet Therapeutics logo

ImmunoMet Therapeutics

immunomet.com

Panacea Pharmaceuticals logo

Panacea Pharmaceuticals

Accelerated Pharma logo

Accelerated Pharma

Blueprint Medicines logo

Blueprint Medicines

Dracen Pharmaceuticals - Quick Facts

Who are Dracen Pharmaceuticals' competitors?

Companies similar to Dracen Pharmaceuticals include Novita Pharmaceuticals, Onchilles Pharma, Cage Pharma and Lite Strategy.

When was Dracen Pharmaceuticals founded?

Dracen Pharmaceuticals was founded in 2016.

Where is Dracen Pharmaceuticals' headquarters located?

Dracen Pharmaceuticals' headquarters is located in Baltimore, MD, US.

When was Dracen Pharmaceuticals' last funding round?

Dracen Pharmaceuticals' most recent funding round was for $2.3M (USD) in August 2023.

How much has Dracen Pharmaceuticals raised to-date?

As of Aug 10, 2023, Dracen Pharmaceuticals has raised a total of $50.9M (USD).

How many employees does Dracen Pharmaceuticals have?

Dracen Pharmaceuticals has 375 employees as of Feb 4, 2024.

Dracen Pharmaceuticals - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatment
Tags
  • Healthtech
  • Pharmaceutical
NAICS
  • 456000Health and Personal Care Retailers
  • 450000Retail Trade
  • 456100Health and Personal Care Retailers
  • 456110Pharmacies and Drug Retailers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 440000Retail Trade
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 5900Miscellaneous Retail
  • 2830Drugs
  • 5910Drug Stores And Proprietary Stores
  • 2834Pharmaceutical Preparations